Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
As Joby Aviation gears up for commercial flights in 2026, investors are weighing a bold ramp in production, regulator...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...
In the wake of after $679 million iran bets, lawmakers are moving to curb and potentially ban prediction markets tied...
As crypto markets stabilize, investors ask if coinbase stock finally buy? signals a bottom. The company shows cash st...
Polymarket is adopting an AI-driven monitoring system from Palantir and TWG Global to police betting activity in real...
Tether launches a $1 billion USDT mint on the TRON network, lifting total circulating supply toward $183 billion as g...
CF Industries climbs as global nitrogen supply tightens and European disruptions spill over into North American marke...
The U.S. government withdraws a global AI chip licensing plan, removing near-term constraints on Nvidia's internation...
NeoCloud stocks jumped on renewed AI compute optimism, led by IREN and CoreWeave, while Mara posted strong momentum l...
Markets are choppy midway through Q1 2026 as earnings season unfolds. This report ranks the best trading platforms fo...
A top market strategist calls for exiting the Magnificent 7 amid lofty valuations and fading earnings promises, hinti...